pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery:in vitroandin vivoevaluation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
pH-responsive thiolated chitosan nanoparticles for oral low-molecular weight heparin delivery:in vitroandin vivoevaluation
Authors
Keywords
-
Journal
DRUG DELIVERY
Volume 23, Issue 1, Pages 238-247
Publisher
Informa UK Limited
Online
2014-05-28
DOI
10.3109/10717544.2014.909908
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In vitro antitumor activity of methotrexate via pH-sensitive chitosan nanoparticles
- (2013) Daniele Rubert Nogueira et al. BIOMATERIALS
- Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: In vitro and in vivo assessment
- (2013) Archana Pataskar Bagre et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Recent advances in chitosan-based nanoparticles for oral delivery of macromolecules
- (2012) Mei-Chin Chen et al. ADVANCED DRUG DELIVERY REVIEWS
- In vitro evaluation of mucoadhesion and permeation enhancement of polymeric amphiphilic nanoparticles
- (2012) Ya Liu et al. CARBOHYDRATE POLYMERS
- Erythrocytes load of low molecular weight chitosan nanoparticles as a potential vascular drug delivery system
- (2012) Wen Fan et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- pH-sensitive polymeric nanoparticles to improve oral bioavailability of peptide/protein drugs and poorly water-soluble drugs
- (2012) Xue-Qing Wang et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- PEG–PLGA based large porous particles for pulmonary delivery of a highly soluble drug, low molecular weight heparin
- (2012) Brijeshkumar Patel et al. JOURNAL OF CONTROLLED RELEASE
- Development and in vitro evaluation of thiolated chitosan—Poly(methacrylic acid) nanoparticles as a local mucoadhesive delivery system
- (2011) Mohammad Reza Saboktakin et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Chitosan nanoconstructs for improved oral delivery of low molecular weight heparin: In vitro and in vivo evaluation
- (2011) Rishi Paliwal et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Biomimetic Solid Lipid Nanoparticles for Oral Bioavailability Enhancement of Low Molecular Weight Heparin and Its Lipid Conjugates:In Vitroandin VivoEvaluation
- (2011) Rishi Paliwal et al. MOLECULAR PHARMACEUTICS
- Development of mucoadhesive thiolated chitosan nanoparticles for biomedical applications
- (2010) A. Anitha et al. CARBOHYDRATE POLYMERS
- Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery
- (2010) Abdallah Makhlof et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Reversal of heparin-induced increases in aPTT in the rat by PM102, a novel heparin antagonist
- (2010) Daniel J. Cushing et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Effective protection and controlled release of insulin by cationic β-cyclodextrin polymers from alginate/chitosan nanoparticles
- (2010) Nan Zhang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Microparticles as a Strategy for Low-Molecular-Weight Heparin Delivery
- (2010) Samantha S.M. Oliveira et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Chitosan-based delivery systems for protein therapeutics and antigens
- (2009) Maryam Amidi et al. ADVANCED DRUG DELIVERY REVIEWS
- The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin
- (2009) Mei-Chin Chen et al. BIOMATERIALS
- Encapsulation of low molecular weight heparins: Influence on the anti-Xa/anti-IIa ratio
- (2009) L. Javot et al. JOURNAL OF CONTROLLED RELEASE
- Synthesis and Evaluation of Pegylated Dendrimeric Nanocarrier for Pulmonary Delivery of Low Molecular Weight Heparin
- (2008) Shuhua Bai et al. PHARMACEUTICAL RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More